Transplant patients call for drug innovation

People who get an organ transplant must take immunosuppressants daily. These drugs can have serious side effects and can cause secondary diseases like diabetes and cancer. And yet, they haven't been updated in more than a decade. Why?

Ken Newell, transplant surgeon at Emory University Hospital. He served as president of the American Society of Transplantation from 2014 to 2015.

William Fitzsimmons, advisor to the Transplant Therapeutic Consortium. He has spent 29 years in the pharmaceutical industry including developing transplant drugs.

Genevieve Morgan, kidney transplant recipient from Portland, Maine.